TMCnet News

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endo International plc and Reminds Investors with Losses to Contact the Firm
[July 01, 2016]

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endo International plc and Reminds Investors with Losses to Contact the Firm


Lundin Law PC announces a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP) concerning possible violations of federal securities laws between March 2, 2015 and May 6, 2016 (the "Class Period"). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 25, 2016, lead plaintiff motion deadline.

To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at [email protected].



No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, the Company failed to disclose that: Endo's arrangements with pharmacy benefit managers ("PBMs") with respect to the migraine therapy Frova included questionable incentives intended to increase sales revenues; and as a result, Endo's revenues and revenue projections relied in part on unsustainable arrangements.


Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]